Wentao Tian

No. 87 Xiangya Road
Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

RFC5 and STAT3 form a transcriptional complex to drive NSCLC progression via c-Myc.

RFC5 and STAT3 form a transcriptional complex to drive NSCLC progression via c-Myc.

Journal: iScience

Published: December 09, 2025

Response to Zhang, Wang, Li, et al.

Response to Zhang, Wang, Li, et al.

Journal: Journal of the National Cancer Institute

Published: May 20, 2025

Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance.

Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: April 17, 2025

A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer.

A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer.

Journal: Scientific reports

Published: July 15, 2024

Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer.

Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer.

Journal: Cancer medicine

Published: May 08, 2024

Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysis.

Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysis.

Journal: Journal of the National Cancer Institute

Published: January 24, 2024

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States.

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States.

Journal: Frontiers in pharmacology

Published: November 04, 2023

First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis.

First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis.

Journal: Therapeutic advances in medical oncology

Published: October 26, 2023

The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury.

The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury.

Journal: International journal of biological sciences

Published: October 14, 2023

Cancer stem cells: advances in knowledge and implications for cancer therapy.

Cancer stem cells: advances in knowledge and implications for cancer therapy.

Journal: Signal transduction and targeted therapy

Published: October 02, 2023

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States.

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States.

Journal: Frontiers in immunology

Published: July 27, 2023

Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials.

Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials.

Journal: Molecular cancer

Published: June 27, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026